SCHEMBL21067701

SCHEMBL21067701

NS(=O)(=O)c1nnc(-c2ccccc2Cl)s1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 10/20 1.00
CA2 P00918 10/20 1.00
CA9 Q16790 6/20 1.00
CA12 O43570 4/20 1.00
CA7 P43166 4/20 1.00
CA6 P23280 3/20 1.00
CA5A P35218 3/20 1.00
CA5B Q9Y2D0 3/20 1.00
CA3 P07451 2/20 1.00
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 2/20 0.58
HPGD P15428 2/20 0.58
HSD17B10 Q99714 2/20 0.58
SCN2A Q99250 1/20 0.50
NPC1 O15118 2/20 0.47
TP53 P04637 1/20 0.47
PKM P14618 1/20 0.47
CASP3 P42574 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SENP8 Q96LD8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28259515 0.76 CA2 (0.61) CA1CA2CA9CA12CA7
SCHEMBL28257304 0.75 CA2 (0.59) CA1CA2CA9CA12CA7
SCHEMBL30314797 0.74 KDM4E (1.00) CA1CA2CA9CA12CA7
SCHEMBL30314798 0.74 KDM4E (1.00) CA1CA2CA9CA12CA7
SCHEMBL11326692 0.74 KDM4E (1.00) CA1CA2CA9CA12CA7
SCHEMBL9848132 0.73 ALDH1A1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL2439298 0.70 ALDH1A1 (0.62) CA1CA2CA9CA12CA7
SCHEMBL21065048 0.70 ALDH1A1 (0.62) CA1CA2CA9CA12CA7
SCHEMBL31328400 0.70 ALDH1A1 (0.62) CA1CA2CA9CA12CA7
SCHEMBL970693 0.70 ALDH1A1 (0.62) CA1CA2CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed